GO:0046459 short-chain fatty acid metabolic process: Gut Microbial Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046459 short-chain fatty acid metabolic process describes all chemical reactions and pathways involving fatty acids with fewer than six carbons, chiefly acetate, propionate, and butyrate.
• These metabolites are produced mainly by gut microbial fermentation of dietary fiber and act as signaling molecules, energy substrates, and epigenetic regulators in the host.
• Short-chain fatty acids influence immune memory, hepatic metabolism, cardiovascular health, and neurological function through receptor-dependent and independent mechanisms.
• Key host sensors include FFAR2, FFAR3, and HDAC inhibition, which link microbial metabolism to gene expression and cellular function.
• Dysregulation of short-chain fatty acid metabolism is associated with metabolic, immune, and neurological diseases, making it a therapeutic target.
• CRISPR-based models (knockout, knock-in, overexpression) enable causal interrogation of genes in this pathway for drug discovery and mechanistic studies.
Description
Short-chain fatty acids (SCFAs) are aliphatic carboxylic acids with fewer than six carbon atoms, predominantly acetate (C2), propionate (C3), and butyrate (C4). The Gene Ontology term GO:0046459, short-chain fatty acid metabolic process, encompasses the chemical reactions and pathways involving these molecules, including their synthesis, interconversion, and degradation. This process is central to host-microbe interactions because SCFAs are produced by gut microbial fermentation of dietary fiber and serve as energy sources, signaling molecules, and epigenetic modifiers. Researchers study this term to understand how microbial metabolism influences host physiology, from immune regulation to metabolic homeostasis. The importance of SCFA metabolism extends to multiple diseases, including metabolic disorders, cardiovascular diseases, and neurological conditions. For example, dietary SCFA intake improves hepatic metabolic condition via FFAR3, and SCFAs promote memory potential of CD8+ T cells. Thus, GO:0046459 provides a framework for investigating the molecular links between diet, microbiota, and human health.
short-chain fatty acid metabolic process At A Glance
| GO ID | GO:0046459 |
|---|---|
| GO term | short-chain fatty acid metabolic process |
| Ontology | biological_process |
| Synonym | short-chain fatty acid metabolism |
| Definition | The chemical reactions and pathways involving a short-chain fatty acid. A short-chain fatty acid has an aliphatic tail containing fewer than 6 carbons. |
| Major function | Metabolism of acetate, propionate, butyrate, and related short-chain fatty acids, influencing energy homeostasis, immune function, and gene regulation. |
| Related receptors | FFAR2 (GPR43), FFAR3 (GPR41), and others that sense SCFAs. |
| Key sources | Gut microbial fermentation of dietary fiber; also endogenous production. |
| Disease relevance | Metabolic, immune, neurological, and cardiovascular diseases. |
What Is GO:0046459?
GO:0046459 short-chain fatty acid metabolic process is defined as the chemical reactions and pathways involving a short-chain fatty acid, which is a fatty acid with an aliphatic tail containing fewer than six carbons. This biological process includes the biosynthesis, elongation, and degradation of SCFAs, as well as their conversion into other metabolites. It is synonymous with short-chain fatty acid metabolism and is a subclass of fatty acid metabolic process. The term is used to annotate gene products that participate in these reactions, such as enzymes, transporters, and receptors that mediate SCFA uptake or signaling.
Why Is short-chain fatty acid metabolic process Important in Cell Biology?
GO:0046459 is important because short-chain fatty acids are key mediators of host-microbiota crosstalk and have profound effects on human health. They serve as energy substrates for colonocytes, regulate immune cell function, and modulate gene expression through histone deacetylase inhibition and G-protein-coupled receptor signaling. Dysregulation of SCFA metabolism is linked to obesity, diabetes, inflammatory bowel disease, and neurological disorders. Understanding this process at the molecular level can reveal therapeutic targets and biomarkers for disease prevention and treatment.
• SCFAs are major products of gut microbial fermentation and influence host energy balance.
• They regulate immune cell memory and function, as shown for CD8+ T cells.
• SCFAs act as epigenetic modulators by inhibiting histone deacetylases, affecting global gene expression.
• Dietary SCFA intake improves hepatic metabolic condition via FFAR3.
• SCFAs are involved in cardiovascular diseases through acylation and receptor signaling.
• Butyrate from Bacteroides vulgatus alleviates heart failure via TGF-β1/MAPK pathway.
• SCFA metabolism is relevant to neurological diseases and metabolic disorders.
• Organic acids including SCFAs can suppress ruminal methane production, linking to agricultural and environmental applications.
• SCFA receptors are therapeutic targets for metabolic, immune, and neurological diseases.
• CRISPR screening can identify genes that regulate SCFA metabolism and signaling.
What Happens During short-chain fatty acid metabolic process?
Microbial Fermentation and SCFA Production
In simple terms: Gut bacteria break down fiber and produce short-chain fatty acids.
The primary source of short-chain fatty acids in the human body is the fermentation of dietary fiber by gut microbiota. Bacteria such as Bacteroides vulgatus and others metabolize complex carbohydrates into acetate, propionate, and butyrate. This process involves a complex microbial community and metabolic networks that can be studied using kinetic and microbial modeling approaches. The production rates and ratios of SCFAs depend on diet, microbiota composition, and host factors.
Host Uptake and Receptor Signaling
In simple terms: Short-chain fatty acids are taken up by host cells and activate receptors.
Once produced, SCFAs are absorbed by colonocytes and enter the bloodstream, where they can activate G-protein-coupled receptors such as FFAR2 (GPR43) and FFAR3 (GPR41). FFAR3 mediates the effects of dietary SCFA intake on hepatic metabolic condition. These receptors are expressed on immune cells, adipocytes, and enteroendocrine cells, linking SCFA metabolism to immune and metabolic responses.
Epigenetic Regulation via HDAC Inhibition
In simple terms: Short-chain fatty acids can change how genes are turned on or off by affecting histones.
Butyrate and propionate are known histone deacetylase (HDAC) inhibitors, leading to changes in chromatin structure and gene expression. Krautkramer et al. showed that diet-microbiota interactions mediate global epigenetic programming in multiple host tissues, with SCFAs playing a key role. This epigenetic regulation affects cell proliferation, differentiation, and immune function.
SCFA Oxidation and Energy Metabolism
In simple terms: Short-chain fatty acids are burned for energy or used to make other molecules.
SCFAs can be oxidized via beta-oxidation to generate ATP, particularly in colonocytes, liver, and muscle. They also serve as substrates for lipid synthesis and other metabolic pathways. The metabolic fate of SCFAs depends on the tissue and the availability of enzymes such as acyl-CoA synthetases and dehydrogenases.
Immune Modulation and Memory Potential
In simple terms: Short-chain fatty acids help immune cells remember past infections.
Bachem et al. demonstrated that microbiota-derived SCFAs promote the memory potential of antigen-activated CD8+ T cells. This effect involves metabolic reprogramming and epigenetic changes that enhance the ability of T cells to form long-lived memory cells. Thus, SCFA metabolism directly influences adaptive immunity.
Key Genes Involved in GO:0046459 short-chain fatty acid metabolic process
The following genes and proteins are key players in short-chain fatty acid metabolic process, including receptors, enzymes, and transporters.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FFAR2 (GPR43) | Receptor for acetate and propionate | Mediates immune and metabolic effects of SCFAs |
| FFAR3 (GPR41) | Receptor for propionate and butyrate | Links dietary SCFA intake to hepatic metabolism |
| HDAC1 | Histone deacetylase inhibited by butyrate | Epigenetic regulation by SCFAs |
| HDAC2 | Histone deacetylase inhibited by butyrate | Epigenetic regulation by SCFAs |
| HDAC3 | Histone deacetylase inhibited by butyrate | Epigenetic regulation by SCFAs |
| ACSS2 | Acetyl-CoA synthetase | Converts acetate to acetyl-CoA for metabolism |
| ACSS3 | Propionyl-CoA synthetase | Activates propionate for metabolism |
| ACADS | Short-chain acyl-CoA dehydrogenase | Beta-oxidation of SCFAs |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Beta-oxidation of SCFAs |
| SLC16A1 | Monocarboxylate transporter | Transport of SCFAs across membranes |
| SLC5A8 | Sodium-coupled monocarboxylate transporter | Uptake of SCFAs in colon |
| TGFB1 | Transforming growth factor beta 1 | Mediates butyrate effects in heart failure |
| MAPK1 | Mitogen-activated protein kinase 1 | Involved in butyrate signaling |
| MAPK3 | Mitogen-activated protein kinase 3 | Involved in butyrate signaling |
| IL10 | Anti-inflammatory cytokine | Induced by SCFAs in immune cells |
| FOXP3 | Regulatory T cell transcription factor | Promoted by SCFAs |
| GPR109A | Receptor for butyrate | Mediates anti-inflammatory effects |
How Is short-chain fatty acid metabolic process Regulated?
Short-chain fatty acid metabolic process is regulated at multiple levels. The composition of the gut microbiota determines the types and amounts of SCFAs produced, influenced by diet and host factors. Host receptors such as FFAR2 and FFAR3 sense SCFA levels and trigger signaling cascades that regulate metabolism and immunity. Epigenetic mechanisms, including HDAC inhibition, modulate gene expression in response to SCFAs. Additionally, SCFA oxidation and transport are regulated by enzyme expression and transporter activity. The TGF-β1/MAPK pathway is involved in butyrate-mediated effects in heart failure.
short-chain fatty acid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FFAR3 | Metabolic syndrome, hepatic steatosis | Knockout mouse, overexpression in liver cells |
| FFAR2 | Inflammatory bowel disease, colitis | Knockout mouse, knock-in humanized receptor |
| HDAC1/2/3 | Cancer, inflammation | Point mutation to disrupt catalytic activity |
| TGFB1 | Heart failure | Knockout mouse, overexpression in cardiomyocytes |
| MAPK1/3 | Heart failure, hypertrophy | Knockout and point mutation models |
Metabolic Disorders
Short-chain fatty acid metabolism is closely linked to metabolic diseases such as obesity and type 2 diabetes. Dietary SCFA intake improves hepatic metabolic condition via FFAR3, suggesting that modulating SCFA signaling could be therapeutic. Dysbiosis of the gut microbiota can alter SCFA production, contributing to metabolic dysfunction.
Cardiovascular Diseases
SCFAs are involved in cardiovascular diseases through acylation and receptor signaling. Butyrate from Bacteroides vulgatus alleviates heart failure via the TGF-β1/MAPK pathway, highlighting a direct link between microbial SCFA production and cardiac function. These findings suggest that SCFA metabolism could be targeted for cardiovascular therapy.
Immune and Neurological Diseases
SCFAs promote the memory potential of CD8+ T cells, which is critical for effective immune responses. They also influence neurological diseases through the gut-brain axis, as reviewed by Ikeda et al.. SCFA receptors are considered therapeutic targets for immune and neurological diseases.
From short-chain fatty acid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FFAR3 mediate hepatic effects of SCFAs? | FFAR3 knockout mouse or CRISPR knockout HepG2 cells |
| How does butyrate affect heart failure? | Bacteroides vulgatus colonization in mouse models, butyrate treatment |
| What is the role of HDAC inhibition in SCFA effects? | HDAC point mutant knock-in cells |
| Can SCFA receptors be targeted for immune modulation? | Knock-in humanized FFAR2/FFAR3 mice |
| What genes regulate SCFA production in microbiota? | CRISPR screening in bacterial strains |
| Does SCFA metabolism influence T cell memory? | CD8+ T cell-specific knockout of SCFA transporters |
How to Study the short-chain fatty acid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GC-MS | SCFA concentrations | Quantification in feces and serum |
| 16S rRNA sequencing | Microbial community composition | Identifying SCFA-producing bacteria |
| RNA-seq | Gene expression changes | Effects of SCFAs on host cells |
| ChIP-seq | Histone acetylation and chromatin state | Epigenetic regulation by SCFAs |
| CRISPR knockout screen | Gene function loss | Identifying regulators of SCFA metabolism |
| CRISPR activation screen | Gene overexpression | Discovering enhancers of SCFA signaling |
| Metabolic flux analysis | SCFA production and consumption rates | Modeling microbial metabolism |
| Western blot | Protein expression and phosphorylation | TGF-β1/MAPK pathway activation |
Metabolomics and SCFA Quantification
Gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC) are used to quantify SCFA levels in biological samples. These methods measure acetate, propionate, and butyrate concentrations in feces, serum, and tissues.
Microbial Community Analysis
16S rRNA sequencing and metagenomics reveal the composition of gut microbiota responsible for SCFA production. Kinetic and microbial modeling approaches can predict SCFA production rates from community data.
CRISPR Screening and Functional Genomics
CRISPR knockout and activation screens can identify host genes that regulate SCFA uptake, signaling, and metabolism. These screens are valuable for discovering new therapeutic targets.
Epigenetic and Transcriptomic Profiling
RNA-seq and ChIP-seq can assess changes in gene expression and histone acetylation induced by SCFAs. These methods help elucidate the epigenetic mechanisms of SCFA action.
How CRISPR Can Be Used to Study GO:0046459 short-chain fatty acid metabolic process
Knockout
CRISPR knockout of genes such as FFAR2, FFAR3, or HDACs can reveal their causal roles in SCFA metabolism and signaling. For example, FFAR3 knockout mice show altered hepatic metabolic responses to dietary SCFAs.
Point Mutation
Point mutations can be introduced to disrupt catalytic activity or receptor binding while preserving protein expression. For instance, mutating key residues in HDACs can test the importance of enzymatic activity in SCFA-mediated epigenetic regulation.
Knock-in
Knock-in of human SCFA receptors into mouse models can humanize the system for drug testing. Tagged knock-in of metabolic enzymes allows tracking of their localization and interactions.
Overexpression
Overexpression of SCFA transporters or enzymes can enhance SCFA uptake and metabolism, providing gain-of-function models to study downstream effects. This approach is useful for validating therapeutic targets.
How EDITGENE Supports short-chain fatty acid metabolic process Research
Researchers studying short-chain fatty acid metabolic process-related genes often need to determine whether a candidate gene is causally involved in SCFA production, sensing, or downstream effects. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for short-chain fatty acid metabolic process research.
Frequently Asked Questions About short-chain fatty acid metabolic process
What is GO:0046459 short-chain fatty acid metabolic process?
GO:0046459 is a Gene Ontology biological process term describing the chemical reactions and pathways involving short-chain fatty acids, which have fewer than six carbons.
What are short-chain fatty acids?
Short-chain fatty acids are fatty acids with an aliphatic tail of fewer than six carbons, such as acetate, propionate, and butyrate.
What genes are involved in short-chain fatty acid metabolic process?
Key genes include FFAR2, FFAR3, HDAC1-3, ACSS2, ACADS, SLC16A1, and SLC5A8, among others.
How are short-chain fatty acids produced?
They are primarily produced by gut microbial fermentation of dietary fiber.
What diseases are linked to short-chain fatty acid metabolism?
Metabolic disorders, cardiovascular diseases, immune diseases, and neurological diseases are linked to SCFA metabolism.
How do short-chain fatty acids affect the immune system?
SCFAs promote memory potential of CD8+ T cells and regulate regulatory T cells through receptor signaling and epigenetic changes.
What is the role of FFAR3 in SCFA metabolism?
FFAR3 mediates the effects of dietary SCFA intake on hepatic metabolic condition.
Can CRISPR be used to study short-chain fatty acid metabolism?
Yes, CRISPR knockout, knock-in, and overexpression models can dissect gene function in SCFA pathways.
What methods are used to measure SCFAs?
GC-MS and HPLC are commonly used to quantify SCFAs in biological samples.
How does butyrate affect heart failure?
Butyrate from Bacteroides vulgatus alleviates heart failure via the TGF-β1/MAPK pathway.
Conclusion
GO:0046459 short-chain fatty acid metabolic process is a critical biological process at the interface of diet, microbiota, and host health. It encompasses the production, signaling, and metabolic fate of acetate, propionate, and butyrate, which influence immune function, metabolism, and disease. Understanding the genes and mechanisms involved can lead to new therapeutic strategies for metabolic, cardiovascular, and neurological diseases. CRISPR-based models and multi-omics approaches are powerful tools to advance this field.
References
- 1. Ikeda T et al.. 2022. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases.. Pharmacol Ther 239:108273 PMID: 36057320
- 2. Bachem A et al.. 2019. Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8(+) T Cells.. Immunity 51(2):285-297.e5 PMID: 31272808
- 3. Atasoy M et al.. 2024. Biobased short chain fatty acid production - Exploring microbial community dynamics and metabolic networks through kinetic and microbial modeling approaches.. Biotechnol Adv 73:108363 PMID: 38657743
- 4. Krautkramer KA et al.. 2016. Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues.. Mol Cell 64(5):982-992 PMID: 27889451
- 5. Shimizu H et al.. 2019. Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3.. Sci Rep 9(1):16574 PMID: 31719611
- 6. Chen XF et al.. 2020. Short-chain fatty acid, acylation and cardiovascular diseases.. Clin Sci (Lond) 134(6):657-676 PMID: 32219347
- 7. Du Z et al.. 2026. Bacteroides vulgatus alleviates heart failure via butyric acid-TGF-β1/MAPK pathway.. J Adv Res 84:991-1004 PMID: 41076121
- 8. Yamada K et al.. 2023. Batch culture analysis to identify potent organic acids for suppressing ruminal methane production.. Anim Sci J 94(1):e13873 PMID: 37721187
